Flagship Ventures Opportunities Fund I General Partner LLC insider trades: Axcella Health (AXLA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Flagship Ventures Opportunities Fund I General Partner LLC reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 13, 2022 | AXLA | ↑ Buy | 5,501,235 | $1.64 | $9.0M | By Flagship Ventures Fund IV, L.P. | Oct 17, 2022 (4d) |
| Oct 13, 2022 | AXLA | ↑ Buy | 3,048,780 | $1.64 | $5.0M | By FPA, L.P. | Oct 17, 2022 (4d) |
| Oct 13, 2022 | AXLA | ↑ Buy | 1,833,745 | $1.64 | $3.0M | By Flagship Ventures Opportunities I, L. | Oct 17, 2022 (4d) |
| May 27, 2022 | EVLO | ↑ Buy | 13,698,630 | $1.46 | $20.0M | By Flagship Pioneering Fund VII, L.P. | Jun 1, 2022 (5d) |
| May 27, 2022 | EVLO | ↑ Buy | 6,849,315 | $1.46 | $10.0M | By Nutritional Health LTP Fund, L.P. | Jun 1, 2022 (5d) |
| May 27, 2022 | EVLO | ↑ Buy | 4,383,561 | $1.46 | $6.4M | By Flagship Ventures Fund IV, L.P. | Jun 1, 2022 (5d) |
| May 27, 2022 | EVLO | ↑ Buy | 1,369,863 | $1.46 | $2.0M | By Flagship Ventures Opportunities Fund | Jun 1, 2022 (5d) |
| May 27, 2022 | EVLO | ↑ Buy | 1,095,890 | $1.46 | $1.6M | By Flagship Ventures Fund IV-Rx, L.P. | Jun 1, 2022 (5d) |
| Mar 16, 2022 | AXLA | ↑ Buy | 3,791,623 | $1.91 | $7.2M | By Flagship Ventures Fund IV, L.P. | Mar 18, 2022 (2d) |
| Mar 16, 2022 | AXLA | ↑ Buy | 1,579,843 | $1.91 | $3.0M | By Flagship Ventures Opportunities I, L. | Mar 18, 2022 (2d) |
| Mar 16, 2022 | AXLA | ↑ Buy | 947,905 | $1.91 | $1.8M | By Flagship Ventures Fund IV-Rx, L.P. | Mar 18, 2022 (2d) |
| Mar 19, 2021 | RUBY | ↑ Buy | 210,000 | $29.00 | $6.1M | Indirect | Mar 23, 2021 (4d) |
| Feb 8, 2021 | KLDO | ↑ Buy | 215,000 | $11.50 | $2.5M | Indirect | Feb 10, 2021 (2d) |
| Feb 2, 2021 | EVLO | ↑ Buy | 130,000 | $15.00 | $1.9M | Indirect | Feb 4, 2021 (2d) |
| Oct 27, 2020 | FHTX | ↑ Buy | 150,000 | $16.00 | $2.4M | Indirect | Oct 29, 2020 (2d) |
| Jun 29, 2020 | EVLO | ↑ Buy | 4,666,666 | $3.75 | $17.5M | Indirect | Jul 1, 2020 (2d) |
| Jun 4, 2020 | KLDO | ↑ Buy | 2,000,000 | $7.50 | $15.0M | Indirect | Jun 8, 2020 (4d) |
| May 18, 2020 | AXLA | ↑ Buy | 3,800,000 | $4.75 | $18.1M | Indirect | May 20, 2020 (2d) |
| May 13, 2019 | AXLA | ↑ Buy | 500,000 | $20.00 | $10.0M | Indirect | May 15, 2019 (2d) |
| Mar 4, 2019 | KLDO | ↑ Buy | 933,333 | $15.00 | $14.0M | Indirect | Mar 6, 2019 (2d) |
| May 11, 2018 | EVLO | ↑ Buy | 281,250 | $16.00 | $4.5M | Indirect | May 15, 2018 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Flagship Ventures Opportunities Fund I General Partner LLC's insider trades
Flagship Ventures Opportunities Fund I General Partner LLC is a 10% owner of Axcella Health (AXLA). Since May 11, 2018, it has reported 21 open-market purchases worth $161.1M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (4 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AXLA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.